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Abstract 
 
Background: Currently available molecular method to detect HER2I655V polymorphism such as PCR-RFLP is hampered 
by the costly experimental method, and post-PCR treatment requirement that makes this technique is not meeting for 
high-throughput analysis purpose. In this study, we developed an accurate, simple, low cost and rapid test to detect 
polymorphism at HER2 gene using SBR Green I based-melting curve method. Methods: Two forward allele-specific 
primers and one common reverse primer were used then these primers were tested to discriminate known genotypes of 
genomic templates (GG type or AA type) and genomic samples retrieved from breast cancer patients. Results: Melting 
curve analysis derived from SYBR Green I-based allele-specific PCR with defined primers concentration and annealing 
temperature at 54.3 °C showed good discrimination level of Tm peaks in which GG genotype melted at 89 °C slightly 
higher than AA genotype which melted at 86 °C, while AG genotype harbored both of homozygous Tm characteristics. 
Conclusions: This preliminary result will be as basic for further large-scale typing of HER2I655V polymorphism. 
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Introduction 
 
Breast cancer, the second leading cause of cancer-related 
death for women, has become global health concern 
with almost 1.5 million women were diagnosed where 
one-third died due to this illness.1 It is estimated that the 
incidence rate of breast cancer will further increase due 
to ‘westernised’ lifestyle adaptation in many developing 
countries.2 For many years, efforts have been conducted 
to elucidate the risk factors that contribute to breast 
tumorigenesis. Nowadays, it was established that 
environmental and genetic factors are the major keys 
that implicate to breast cancer risk.3,4 Indeed, much of 
studies have clearly shown how the aberrant genetic 
factors could induce carcinogenesis in the breast, 
indicating the accumulative effect of such event that 
collectively increases breast cancer risk.5  
 
Elucidating the genetic predisposition of breast cancer 
risk has risen the importance of genetic variants named 
single nucleotide polymorphisms to breast cancer 
development and progression.6 One of the genes that 
contains genetic variant whose function in breast cells is 
very significant named HER2.7 It is believed that the 
aberrant of this oncogenic gene leads breast cells to 
uncontrol growth and tumour induction.8 Genetic 
variant of this gene is exclusively found at codon 655 
(isoleucine or valine) located at the transmembrane 
domain of the HER2 protein.9 This amino acid changing 
mainly isoleucine to valine was presumed to increase the 
ability of breast cells to transform through receptor 
activation by mimicking ligand induction.10 Indeed, 
case-control study conducted by Xie, et al.11 in Chinese 
women population highlighted the role of HER2 
polymorphism as a susceptible biomarker for breast 
cancer risk. Women whose HER2 contains Val 
(GTC)/Val (GTC) or Ile (ATC)/Val (GTC) variant tend 
to have more breast cancer risk than its wild variant.12 
Independent studies also strengthen how this allelic 
imbalance significantly contribute to breast cancer 
development.13 
 
Predicting the types of HER2I655V polymorphism precisely 
in a population will significantly impact not only on the 
development of antibody-based anticancer drugs but 
also improvement of the care quality for breast cancer 
patients. Currently, a commonly available method with 
routine use for detecting HER2I655V polymorphism in 
breast cancer is Polymerase Chain Reaction-Restriction 
Fragment Length Polymorphism (PCR-RFLP).11,13-15 
Although this method offers superiority in term of sensitivity, 
and specificity yet post-PCR processing step such as digesting 
enzyme treatment and agarose electrophoresis to visualise the 
result is mandatory before the data could be retrieved.16 These 
additional steps of method cause the analysing more 
costly and most importantly that it will be a time-
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consuming procedure. Moreover, an involvement of 
cancer-inducing agent such as ethidium bromide during 
visualising steps further brings the additional issue such 
as safety aspect for laboratory workers.  
 
To be considered as standard tools for diagnostic 
purposes, a method must be accurate, cost effective, and 
fast enough to allow the automated testing of large 
numbers of samples without omitting its sensitivity, 
specificity, reproducibility, precision, and high-throughput 
capability.17 The invention of real-time PCR the machine 
has open widely to the new area of method developing for 
polymorphisms detection.18 Indeed, such multiplex-based 
real-time PCR usually involves no/less-carcinogenic 
dyes such as SYBR Green I as a labelling agent.19 This 
automated assay could be performed due to melting curve 
analysing is based on differentiating double-stranded 
from single-stranded DNA by changes in fluorescence 
intensity in the present of DNA-binding dyes at melting 
temperature condition.20,21 Although, application of such 
SYBR Green I-based melting curve analysis has been 
widely applied in the variety of molecular diagnostics,22-
27 yet studies related to the application for HER2I655V 
polymorphism detection especially in the case of breast 
cancer experiment, no reports have been published. 
 
In this study, we developed the HER2I655V genotyping 
assay by integrating allele-specific PCR with melting 
curve analysis using SYBR Green I, avoiding subsequent 
post-PCR treatments hence far from chemical and 
physical dangers. This technique also provides multiplex 
genotyping assay in the single tube format with accurate, 
rapid and inexpensive cost, allowing high-throughput 
HER2I655V is genotyping. 
 
Methods 
 
Samples collection and genomic DNA extraction. Ten 
tissue samples of 10 breast cancer patients were collected 
from M. Djamil Padang hospital, West Sumatra province 
as frozen section sample. Genomic DNA were extracted 
using Pure Link Genomic DNA Mini Kit (Invitrogen, 
Thermo Fisher Scientific Inc., America) followed manual 
instruction using 10-20 mg of tissue as starting material 
to be extracted while plasmid extraction was extracted 
from overnight culture of recombinant Escherichia coli 
DH5α (collection of Molecular Biology and Diagnostics 
Laboratory, Research Center for Biotechnology-LIPI) 
using high Speed Plasmid Mini Kit (Geneaid Biotech 
Ltd. Taiwan) followed manual instruction with 30 µl of 
ddH2O applied to elute recombinant plasmid. The 
integrity of all genomic DNA was checked using 0.8% 
agarose and the DNA content was also measured using 
spectrometer (Gene Quant TM Pro RNA/DNA calculator, 
GE Healthcare Biosciences). Two genomic DNA and 
pGEM_HER2/AA with known their genotype were also 
prepared. Their polymorphisms have been checked using 
Sanger sequencing and allele-specific PCR.28 For all 
subject enrolled in this study was approved by local ethics 
committee issued from Ministry of Health, Republic of 
Indonesia. 
 
Sensitivity test of Allele-Specific PCR. This test was 
done using PCR supermix reagent purchased from 
Invitrogen. The composition for each PCR components 
followed the instruction except primers; we used 200 
pmol each. Two specific allele primers with forwarding 
direction (HER2_GG: 5'GCGGGCAGGGCGGCGGGG 
GCGGGGCC-CCAGCCCTCTGACGTCCACCG'3 and 
HER2_AA: 5'CCAGCCCTCTGACGTCCAGCT'3) and 
one common reverse primer (HER2_R:5'CGTGTACTT 
CCGGATCTTCTGCTG'3) were used followed methods 
Bui, et al.,29 and Germer and Higuci.30 The Genomic DNA 
(182 ng/µL stock) with GG genotype and pGEM_HER2 
(182 ng/µL stock) with AA genotype were used as a 
template. Serial dilution was done 10 to 100 times from 
each stock then mixed to create genomic DNA that 
contains both of genotype that mimics AG genotype in 
nature. Amplification condition consisted of a 5 minutes 
pre-incubation period at 95 °C, followed by 35 cycles of 
denaturation at 95 °C for 30 seconds, primer annealing 
carried out for 1 minutes at 51.5 °C and extension were 
at 72 °C for 30 seconds. The PCR product was checked 
on 2% of gel agarose.  
 
HER2I655V genotyping using SYBR Green I and melting 
curve analysis. This analysis was done using CFX96 
Real-Time PCR (Biorad Laboratory Inc, USA). Primers 
concentration applied in this experiment followed 
formulation as suggested by Darawi, et al.31 Allele-specific 
PCR composition for each reaction was 10 µL for final 
volume of each reagent as followed: 1x SsoAdvance 
Universal SYBR Green Supermix, 0.06 pmol HER2_GG 
primer, 0.1 pmol HER2_AA, 0.15 pmol HER2_R, DNA 
template at the range of 0.07-0.158 ng and the rest is 
dH2O to gain the final volume of 10 µL as stated in the 
kit except for primers concentration it was modified 
slightly.Allele-specific PCR amplification profile was as 
follows: initial denaturation at 95 °C for 5 minutes, 
followed by 35 cycles of denaturation at 95 °C for 20 
seconds, temperature annealing at 54.3 °C, for 20 seconds, 
and extension at 72 °C for 30 seconds. The fluorescence 
melting curve was analysed immediately following 
amplification. After amplification, the fluorescence 
intensity of the PCR product was measured from 65-95 
°C with 0.5 °C/cycle increment. One sample PCR 
reaction with no contain DNA was also included in the 
experiment to clarify PCR contamination. 
 
Results 
 
Firstly, the sensitivity of the method was evaluated 
especially in the case of heterozygote (AG type) using a 
mix of two genomic DNA template with known 
genotype by dilution from 10 up to 100 times. The 
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effect of DNA template dosage followed inversely the 
ratio of DNA amount added with 100 dilution factor 
exhibiting the best polymorphism discrimination as 
marked by the appearance of two allele-specific PCR 
product sizes which referred to AA type and GG type 
(Figure 1).  
 
The melting curve analysis for each corresponding 
HER2I655V genotypes showed that GG genotype exhibits 
Tm value slightly higher than AA genotype while AG 
genotype produces two different Tm values that refer to 
each of homozygote type (Figure 2). The extra poly-GC 
on a primer that was amplified as GG genotype produce 
higher of GC content that impacts directly on its Tm 
value and PCR product stability. 
 
To confirm the ability of method in detecting poly-morphism, 
10 samples of breast cancer patient with unknown their 
HER2I655V polymorphism were enrolled with three 
replication to ensure reproducibility of the assay. The 
integrity and quantity of the genomic DNA vary but overall 
that genomic DNA is acceptable to be used in method 
confirmation (Figure 3). 
 
Tm curve analysis on 10 samples tested showed that 50% of 
samples belong to AA genotype while another half were AG 
genotype. No GG type was observed from 10 samples tested 
(Figure 4). Comparing this result with another established 
method such as Sanger sequencing, allele-specific Tm curve 
method exhibited closely 100% accordance among genotype 
tested, except for one sample 
 
 
 
Figure 1.  Allele-specific PCR Result of each HER2I655V 
Genotype. Lane 1; 100 bp of DNA Ladder, Lane 
2; Genomic DNA with GG Genotype (182 ng/µL 
stock), Lane 3; Genomic DNA with AA Genotype 
(182 ng/µL stock), Lane 4; mix of 2 and 3 after 
10 Time Dilution, Lane 5; mix of 2 and 3 after 
100 Time Dilution. Red Arrow and Blue Arrow 
Sequentially Refers to GG Type (166 bp) and 
AA Type (116 bp)  
 
 
 
 
 
 
Figure 2.  Tm Values for Each Type of HER2I655V Poly-
morphism 
 
 
 
 
Figure 3.  Genomic DNA Extraction Result from 10 Samples 
of Breast Cancer Patients 
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Figure 4.  Melting Curve Analysis of HER2I655V Poly-
morphism from 10 Samples of Breast Cancer 
Patients. Red Line showed Samples with AA 
Type; Green Line showed Samples with AG Type 
while NTC (Non-Template Control) was Pointed 
by Black Line. The Number of Replicate for Each 
Sample is 3 Times 
 
 
Table 1.  Comparison Result of Melting Curve with 
Established Genotyping Method  
 
HER2I655V 
Genotypes 
Samples positivity 
(% distribution) 
Melting curve 
method 
Sanger sequencing 
method 
AA 5 (50%) 5 (50%) 
GG - 1 (10%) 
AG 5 (50%) 4 (40%) 
Total 10 (100%) 10 (100%) 
 
 
showed AG genotype by this method but presenting GG 
genotype based on Sanger sequencing, indicating there 
was a minor difference between methods as result of 
dissimilarity in their detection sensitivity level (Table 1).  
 
Discussion 
 
The success of genotyping analysis using allele-specific 
PCR relies on how good enough each of specific PCR 
products could be differed clearly on gel agarose without 
producing an ambiguous interpretation. Due to the 
nature of specific primers designed in this method, the 
preferential amplification of one of the alleles may occur. 
As mentioned by von Ahsen, et al.32 The genotyping of 
heterozygous samples requires special consideration due 
to the present both of allelic types in a single sample, 
reducing the amount of template is one of an alternative 
way to increase the probability of minor allele to be 
amplified equally during PCR reaction. Although the 
AG genotype could be well discriminated using this 
method, yet the thickness of the two PCR products 
observed on agarose seems imbalanced. Other factors 
such as the concentration of MgCl2, the unit of Taq 
polymerase and the proportion of primers concentration 
added into PCR solution are also the essentials 
substance that determines the success of polymorphism 
detection using allele-specific PCR.33 
 
We have observed that two genotypes exhibited distinct 
Tm curve profile where GG genotype showed 3 °C higher 
of Tm value compared with AA genotype although the 
single peak of specific Tm was only observed in AA 
genotype. The peaks and its sharpness among genotypes 
observed on melting curve profile will solely depend on 
their GC content, sequence length, type of dyes, the 
concentration of primers annealing temperature of primers 
and dosage of DNA template used.6,31,34-36 The important 
point to be highlighted in this result is that the two 
peaks between two different genotype still could be seen 
clearly event though the DNA dosage used in PCR 
solution is low, Indicating the melting curve method 
improves the sensitivity of genotype detection. Marin, et 
al.37 have observed that allele-specific PCR produces a 
missing result as much as 20-21% while only 1.3% had 
missing by melting curve analysis. Moreover, they also 
suggest that to obtain the similar pattern and well 
discriminated of melting peaks for each genotype, the 
use of 3-25 ng of genomic DNA as a template in allele-
specific PCR recommended. The unspecific peak that 
arises below 80 °C of Tm value is primer dimer due to 
too low annealing temperature applied in PCR process. 
This similar event was observed in another study that 
stated low annealing temperature used in genotyping 
human rotavirus generates unspecific PCR product 
whose Tm is below 77 °C.38 We predicted that our method 
improvement in this study is related to the proportion of 
primers concentration and annealing temperature applied 
beside DNA dosage usage.  
 
The choice of molecular methods for gene polymorphisms 
studies must consider several aspects of methods 
feature, and usually, methods with high sensitivity, 
specificity, reproducible, robustness, and low-cost are 
the most researchers used. Beside specific enzymes 
restriction-based PCR, another method that currently 
applied for polymorphisms studies is probe-based Real-
Time PCR due to high specificity detection produced.39,40 
Nevertheless, such methods require additional primer 
design that contains costly specific probe that hampers to 
diagnostics purpose with prerequisite low-cost 
technology. In our study, we have improved allele-
specific PCR for HER2I655V polymorphism detection 
using DNA binding agent such as SYBR Green I dye in 
PCR-ready used format. This strategy with optimised 
PCR condition (suitable primers ratio, DNA template 
dosage, and short DNA target) have been proven to be 
well performed in discriminating each of HER2I655V 
without any further additional chemicals agent such as a 
probe. One particular caution in applying SYBR Green 
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I-based melting curve method for poly-morphisms 
studies  should keep in mind that the DNA target must 
be 50-200 bp in length to prevent unspecific binding of 
the dye due to influence of dye concentration and DNA 
dosage used.6,35,41 
 
Another important issue regarding single nucleotide 
polymorphisms studies using DNA binding dye-based 
Tm shift genotyping method is possibility occurrence of 
variety in Tm values for the same genotype due to the 
different in PCR instruments usage. This event have 
been observed in genotyping study of sickle cells 
anemia-related genes using High Resolution DNA 
Melting  Analysis (HRMA) where the resolution of the 
melting curve varied among PCR instruments tested, 
with a 15-fold difference in Tm SD (0.018 to 0.274 °C) 
and 33 fold (SYBR Green I) difference in the signal-to-
noise ratio.42 Based on this finding, the Tm values of each 
HER2I655V genotype obtained in our study may produce 
slight different Tm value when another type of PCR 
instruments applied, yet the predicted Tm values will 
probably be around at 85.98-86.27 °C for AA genotype 
and at 88.92-89.27 °C. for diagnostics purpose, we strongly 
recommended for the user to do a comparison study of 
different PCR instruments before the real test done.  
 
The allele frequency of genes in genotyping studies is a 
very important aspect to obtain the solid conclusion in 
term of SNP association to some diseases. We have 
shown that allele-specific PCR in our study is as good 
as Sanger sequencing in HER2I655V polymorphism 
detection. Both of methods produce the same allelic 
frequency distribution which is 0.5 for Ile (AA 
genotype) and 0.5 for Val (AG combined with GG 
genotype). However, Xie, et al.11 obtained values which 
are 0.84 for Ile and 0.16 for Val from 339 patients with 
breast cancer from a Chinese population. This 
discrepancy probably due to the small size of sample 
enrolled in our study. Keshava, et al.7 found that the 
frequency allelic of HER2I655V varied significantly by 
race. This is the limitation of our study which used only 
10 DNA samples of breast cancer. Further study needs to 
be conducted using adequate samples, adding more 
breast cancer samples to comply statistics prerequisite 
to clarify and validate our result. Melting curve method 
has been applied successfully to detect a 
BDNFVal66Met polymorphism,41 chicken Mx gene 
G2032A SNP, and GSTT1, and GSTM1 null 
polymorphism.37 Overall, this result showed that melting 
curve method in our study well performed to 
discriminate each type of HER2I655V polymorphism in 
breast cancer. 
 
Conclusions 
 
SYBR Green I-based melting curve method has been 
developed with success, and it well performed to detect 
HER2I655V polymorphism in breast cancer. This 
preliminary result will be a basic for further large-scale 
HER2I655V genotyping in breast cancer.  
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